Jonathan Violin, Ph.D.

Jonathan Violin, Ph.D.

Former President, Chief Executive Officer and DirectoratViridian Therapeutics, Inc.\DE· In proxies 2022–2023

Pay in FY2023-52% from the year before · Viridian Therapeutics, Inc.\DE stock -25.4% the same year

Jonathan Violin, Ph.D. was paid $2.2M in FY2023 (Dec), down 52%. Viridian Therapeutics, Inc.\DE stock fell 25.4% that year.

Pay$100 in the stock at the end of FY21 → $110
Pay is from the Summary Compensation Table of each Viridian Therapeutics, Inc.\DE proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Viridian Therapeutics, Inc.\DEPublic company · 4 yr
    • Former President, Chief Executive Officer and Director2022 – Present · 4 yrStock in role +16%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?